China grants country's first Covid-19 vaccine patent

Chine  has granted the its first patent for a COVID-19 vaccine . The patent was jointly applied for by a research team with the Academy of Military Sciences and CanSino Biologics Inc., a Chinese high-tech biopharmaceutical company.
The team led by Chen Wei, a researcher at the Institute of Military Medicine under the academy, developed the recombinant COVID-19 vaccine, with the modified defective adenovirus as the vector, reports  Xinhua.
In March 2020, the vaccine became the first in China to be approved to enter clinical trials.
The vaccine has now finished phase-1 and phase-2 clinical trials, which have verified its safety and immunogenicity, said the report .
Besides China , Russia has begun production of the first batch of vaccines against COVID-19 Sputnik V , its health ministry said in a statement released  on 15th August .

Saudi Arabia said this month it plans to begin Phase III clinical trials for the CanSino vaccine. CanSino has said it is also in talks with Russia, Brazil and Chile to launch Phase III trials in those countries.